MIM
MYOV

Monashee Investment Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Monashee Investment Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-130,004
Closed -$1.18M – 195
2019
Q2 		$1.18M Sell
130,004
-50,413
-28% -$752K 0.3% 81
2019
Q1 		$4.31M Buy
+180,417
New +$3.69M 0.99% 30

Other funds holding MYOV

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Monashee Investment Management's MYOV Position: Q3 2019 in Review

Monashee Investment Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2019, closing a stake of 130,004 shares — an estimated $1.18M sold.

Monashee Investment Management first reported a position in MYOV in Q1 2019 and held it in 2 quarters. The position peaked at $4.31M in Q1 2019. 65 funds tracked by Wall St. Rank hold MYOV as of Q3 2019.

  • Monashee Investment Management reported no remaining Myovant Sciences Ltd. position as of Q3 2019 after selling out during the quarter.
  • Monashee Investment Management sold 130,004 Myovant Sciences Ltd. shares in Q3 2019, an estimated $1.18M.
  • Monashee Investment Management first reported a position in Myovant Sciences Ltd. in Q1 2019 and held it in 2 quarters.
  • Monashee Investment Management's Myovant Sciences Ltd. position peaked at $4.31M in Q1 2019.
  • 65 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2019.

Based on Monashee Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.